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Why do hospital doctors wear white coats?
I read with interest the article on doctors and white coats (January 1991 JRSM, p 43) .
In the 1930s I saw that at University College Hospital the students wore short white coats in the wards and thought how hygienic and how much better they looked for attending patients than the students at my hospital, the Royal Victoria Infirmary, Newcastle upon Tyne who in Oxford bags, plus-fours and suits looked unhygienic and unsuitable.
When in 1939 I was appointed Clinical Sub-Dean I immediately ruled that students doing surgical dressing and medical clerking must wear white coats. I knew they had them for the last year for dissection in anatomy. My friend James Spence (later Sir James), Professor of Child Health, came to see me furious, said I was introducing regimentation and wanted to express his disapproval.
I did not foresee difficulties with laundering and managed to arrange for the hospital to carry it out. Then came the war with clothes rationing if new coats had to be purchased. I got the authorities to agree that a certificate from me would allow a white coat to be purchased independently of the ration except for myself. It was not allowed for a person to give a certificate in favour of himself.
I would like to ask those who are not in favour of doctors wearing white coats whether they would approve of nurses wearing their ordinary clothes when on duty in the wards. C N ARMSTRONG 71 Briardene Crescent, Newcastle upon Tyne NE3 4RX
The article by Farraj and Baron on white coats (January 1991 JRSM, P 43) made interesting reading. When I went to St Mary's in 1947, a student was not allowed on the wards unless wearing a short white coat. A houseman wore a full-length coat -with such a change in status, it did not need to be compulsory! Other doctors also wore white coats apart from a few who had come straight from Harley Street. Porters and others wore grey or buff coloured coats.
Forty years on, I do not wear a white coat: I hasten to add that, apart from parking my car for Saturday shopping in the West End, I have not been to Harley Street for nearly 40 years. I disagree with those who replied to the authors' questionnaire; now, so many people other than doctors wear white coats that it has lost any significance; the administrators say white is cheaper than other colours. D J Over the centuries doctors have dictated the terms of treatment to their patients. It is only with the recent trend of medical treatment 'being bought' by the patients that patients can afford to be choosers.
The doctor-patient relationship which prevailed in the era of Hippocrates must have been entirely different from how medical profession and its delivery is viewed today. The onus of responsibility then (the Greek civilization, Era of Hippocrates) was on the physicians. The holiest of all professions was to dispense its services without yearning for materialistic rewards. Whatever gains to come for the physicians were to help sustain and not to flourish. However, the need to have a Hippocratic Oath itself suggests that at least some corrupt physicians took undue advantage of their professional excellence over the receivers of care at their disposal.
Money, food and sex have long been regarded as three essential modes of transaction of merchandise. Food, the essential component of habitation and money, leapt out of bounds of ethical values and were permitted to be the means of reward and gratitude to the physicians by their indebted patients. Sex, the third essential barter currency of older times, however, continued to tease the masters of morality.
The power in the hands of physicians was immense until recently. The word of the physician was not to be challenged, his decisions not to be questioned because a disaster may befall if he fails to perform his 'rituals' properly. The patient, at the receiving end, was not in a position to pay the physician 'appropriately'. A reward asked by this holy one, was difficult to refuse, in whatever form it was asked.
This trend has changed in recent times and a physician now is not to be rewarded, but paid. Appropriate payment has to be negotiated in a contract prior to the initiation of treatment. The recent interest in doctor-patient sexual relationships does not highlight a new phenomenon. It only reflects the expression of a long-lasting malpractice because of the changing trend and viewpoint of the society. Now that the 'consumers' have started questioning the authority of physicians and even challenge their capability (in a way), the physician can only receive a fee and that too which they (the consumers) approve. Physicians too have accepted that they can be paid for their services -they naturally need not be 'rewarded'. D K ARYA Pastures Hospital, Mickleover, Derby DE3 5DQ
Failure of cancer research
Temple and Burkitt (February 1991 JRSM, p 95) have confronted us with the unadvertised reality that experimental cancer research has failed to reduce the overall mortality from cancer. But the 'major reappraisal of how the problem of cancer is approached' which they call for demands a ruthless audit of how the limited resources for cancer research have been spent over the decades. Have there been sinks of expenditure on ill-conceived strategies which continue to yield nothing of assistance to prevention or management of the disease? Two examples stand out.
For the greater part of this century an expensive search for human oncogenic viruses has gone on without intermission. Whole institutes have been set up which were dedicated to this vast quest. The original (unrealistic) promise of prevention of the disease by hygiene or mass immunization against oncoviruses dies hard. And there never has been any prospect that a tumour initiated by virus would invite some uniquely more effective treatment. In spite of the recent replacement of herpes simplex virus type 2 by a sequence of numbered strains of human papilloma virus as a mooted 'cause' of carcinoma of the cervix, it is true to say that over 50 years of intensive research has failed to prove that any form of cancer prevalent in the UK is virus-induced.
The second big sink for research funds has been the quest, as hoary and trite as the first, for effective immunotherapy. By the beginning of the 1980s over a quarter of the articles in leading cancer journals were on the topic of tumour immunology, and over 400 registered clinical trials of immunotherapy were in progress; yet it is not established as the optional or preferred treatment for any type of cancer -not even for choriocarcinoma, the one clinical cancer whose potential immunogenicity is certified by its allograft status. Contrary to popular belief, potential or manifest immunogenicity has not been demonstrated in any of a wide variety of naturally-arising experimental animal tumours kept free from superimposed artefactual immunogenicity.
These two idees fixes have surely had a long enough run for their money. It behoves cancer research funding agencies to reinvest the money and endeavour in enterprises whose prospects have not been so decisively closed; their scientific committees need to be more alert to 'enthusiasm masquerading as originality' (Gibbon When is treatment economically justified?
Professor Berlin (December 1990 JRSM, p 811) makes an important point regarding the difficulty reconciling 'thinking in economical terms' and the Hippocratic Oath. However, I fear that this is lost among a number of inaccuracies which serve only to diminish the strength of his argument.
For example, commenting on Jennett and Buxton's discussion paper on 'When is treatment for cancer economically justified?' (January 1990, JRSM, p 25), he states that he was 'rather astonished' to read that 'the utilization of health care resources will (my emphasis) be granted to some and denied to other patients'. However, this is, of course, what is already happening, albeit implicitly. Waiting lists are but one example of rationing of health care. Our aim should be that decisions regarding resource allocation are made explicitly, and not allow them to be made, worst of all, by a process of selective neglect.
Further, Berlin states that active palliation therapy justifies 'significant expenditure', a statement with which almost all would agree. The problem comes in defining 'significant'. The notion of 'cost' in economic terms is not one of 'pounds and pence' alone, but of 'sacrifice'; what other alternative to which resources could have been allocated is forgone by following the chosen option? Attaching a monetary value to this is merely a way of objectively measuring cost and enables comparisons to be made. One possible way of doing this is to consider the cost per QALY of different procedures as Jennett and Buxton discussed, using the QALY as a standard measure of outcome.
The question, then, is not 'how much is the patient worth?'; rather, it is 'how much is the treatment worth?' Medical practitioners are best placed to determine this and should do so in the knowledge that if they do not, it may be done less well by others'. However, that it must be done, perhaps sooner rather than later, should not be in doubt. BMJ 1988; 297:471-2 Gastric sarcoidosis
We read the recent case report on gastric sarcoidosis with interest (January 1991 JRSM, p 50). However, we feel that some of the authors comments on the rarity of gastric involvement in sarcoidosis are erroneous.
Certainly we would agree that symptomatic gastric involvement by sarcoidosis is rare and that isolated gastric sarcoidosis, when the difficult differential diagnosis from granulomatous gastritis must be made, is extremely rare.
However, asymptomatic involvement of the stomach in patients with sarcoidosis is relatively common and occurs in at least 10% of cases'. Endoscopic examination, and in particular the appearance of the gastric mucosa, in these patients may be normal and unless multiple biopsies of apparently normal mucosa are taken the diagnosis may be missed. Failure to appreciate this may have resulted in underdiagnosis of asymptomatic gastric sarcoidosis and the impression that it occurs only rarely. Clin Med 1958; 52:231-4 Schubert and Salieri
C D GEORGE
The recent letter by Schoental discussing the death of Franz Schubert (December 1990 JRSM, p 813) followed one by Jackson concerning Mozart's death (December 1990 JRSM, p 813) . Seeing these two great names so close together on the same printed page reminded me of an interesting story connecting these two musical geniuses. While the actual cause of Mozart's death continues to fascinate people", the possibility that Mozart's contemporary and rival, Italian composer Antonio Salieri, might have had something to do with it has for a long time been a rich source of speculation. Pushkin's 19th century play 'Mozart and Salieri' and more recently Peter Shaffer's hugely successful drama 'Amadeus' have perpetuated the theorizing. The motive attributed to Salieri has usually been his jealousy of Mozart's great talent.
A short biography of Franz Schubert by Percy A Scholes that I read as a youths might perhaps serve
